Language: English About HAL Allergy One of the European top players in the field of allergy immunotherapy Over the years HAL Allergy grew to one of the European top players in the field of allergen immunotherapy and has an internationally leading role in the production of modified allergen extracts for both, therapeutic and diagnostic purposes. For this purpose HAL Allergy established a state-of-the-art GMP production in the Leiden Bio Science Park in 2009, enabling increased production capacities. In terms of technology, cutting-edge equipment is installed and the laboratory utilizes advanced equipment. This allows HAL Allergy to further improve its future growth demands and continue on its mission to improve the quality of life of patients by providing biopharmaceutical products for causal treatment. Read more about HAL Allergy in our new corporate brochure 60 years of allergy research, development and production of casual treatments Founded in 1959, HAL Allergy started as a small laboratory in Haarlem, the Netherlands. On request of several local general practitioners, extracts were prepared on a named patient basis to treat allergic reactions. Ever since the core business of HAL Allergy was, and still is, the development, production and distribution of allergen immunotherapies for the treatment and prevention of allergic diseases. Past – Present – Future: HAL Allergy’s roadmap to success Contact Company Information Terms of Use Privacy & Cookie Policy Distributors © Copyright 2020 HAL Allergy B.V., All rights reserved. Design by AJB. HAL Allergy uses cookies to optimize the design of and continuously improve this website. By continuing your visit of the website, you consent to the use of all cookies. If this is not what you want, please go to Settings and more information to find out which cookies we place and make your choice. I accept Privacy settings